Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$48.88 +0.77 (+1.60%)
At close: Oct 21, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Long-Term Debt Repayments (2010 - 2026)

Updated

Rigel Pharmaceuticals' Long-Term Debt Repayments came in at $47.75 million for Q2 2026, up 536.7% from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Long-Term Debt Repayments (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Rigel Pharmaceuticals reported Long-Term Debt Repayments of $55.25 million; for FY2025, it was $7.5 million.

  • The Q2 2026 figure represents the highest quarterly Long-Term Debt Repayments in data going back to Q3 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Rigel Pharmaceuticals 906.93 Mn 372.82 Mn 70.18 Mn 47.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47.75 Mn
Mar 31, 2026 7.50 Mn
Dec 31, 2011 134,000.00
Sep 30, 2011 181,000.00
Jun 30, 2011 234,000.00
Mar 31, 2011 251,000.00
Dec 31, 2010 265,000.00
Sep 30, 2010 269,000.00
API Access

Rigel Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=RIGL&period=max&api_key=YOUR_API_KEY